Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-03-14
1991-01-29
Wax, Robert A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514253, 544360, 544364, A61K 31495, C07D41714
Patent
active
049886991
ABSTRACT:
Substituted tetrahydrobenzothiazoles are described, as well as methods for the preparation and pharmaceutical composition of same, which are useful as dopamine agonists with selectivity for the presynaptic dopamine receptor and are useful as dopaminergic, antipsychotic, and antihypertensive agents as well as for treating hyperprolactinaemia-related conditions and central nervous system disorders.
REFERENCES:
patent: 3944551 (1976-03-01), Regnier
patent: 4260610 (1981-04-01), Regnier
patent: 4308266 (1981-12-01), Seiler
patent: 4613601 (1986-09-01), Regnier
patent: 4731374 (1988-03-01), Griss
Caprathe Bradley W.
Jaen Juan C.
Wise Lawrence D.
Tinney Francis J.
Tsung Frederick F.
Warner-Lambert & Company
Wax Robert A.
LandOfFree
Substituted tetrahydrobenzothiazoles as dopaminergic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted tetrahydrobenzothiazoles as dopaminergic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted tetrahydrobenzothiazoles as dopaminergic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-814006